Outcomes of concurrent versus sequential icotinib therapy and chemotherapy in advanced non‐small cell lung cancer with sensitive EGFR mutations

Yun Zhang(University of Michigan), Lingxin Feng(Qingdao University), Hong Ge(Nanfang Hospital), Zhuang Yu(Shanghai East Hospital), Jing Wang, Linwei Zhang(Huazhong Agricultural University)

Clinical and Translational Science

December 31, 2020

10.1111/cts.12951

Cited by 6

Related Papers

Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer

|JAMA|2018|410

Microbiome and tryptophan metabolomics analysis in adolescent depression: roles of the gut microbiota in the regulation of tryptophan-derived neurotransmitters and behaviors in human and mice

|Microbiome|2023|233

Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)

|Journal of Clinical Oncology|2022|177

A Wireless Capsule Endoscope System With Low-Power Controlling and Processing ASIC

|IEEE Transactions on Biomedical Circuits and Systems|2009|148

Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial

|The Lancet Respiratory Medicine|2019|139